# Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

> **NCT01796821** · PHASE2 · COMPLETED · sponsor: **G&E Herbal Biotechnology Co., LTD** · enrollment: 138 (actual)

## Conditions studied

- Condyloma Acuminata
- Genital Warts
- Condylomata Acuminata
- Venereal Warts

## Interventions

- **DRUG:** Vehicle gel
- **DRUG:** SR-T100 gel with 1.0 % SM
- **DRUG:** SR-T100 gel with 2.3% SM

## Key facts

- **NCT ID:** NCT01796821
- **Lead sponsor:** G&E Herbal Biotechnology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2018-09
- **Final completion:** 2018-10
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796821, "Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01796821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*